This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Drug price concerns motivate US patent reform efforts

By Nick Robertson ( October 22, 2025, 17:58 GMT | Insight) -- Public concerns over the price of prescription drugs are fueling interest in reforming US patent law, according to a new survey by reform advocacy group Initiative for Medicines, Access and Knowledge. Vermont Democratic Senator Peter Welch held up his attempts to limit so-called "patent thickets" as a potential solution.An overwhelming bipartisan majority of Americans wants Congress to act to reduce prescription drug prices, and a majority see efforts to bring generic medications to the market sooner via patent reform as a viable path, according to a new survey....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections